C-type natriuretic peptide in human coronary atherosclerotic lesions

被引:58
|
作者
Naruko, T
Ueda, M
vanderWal, AC
vanderLoos, CM
Itoh, H
Nakao, K
Becker, AE
机构
[1] UNIV AMSTERDAM, ACAD MED CTR, DEPT CARDIOVASC PATHOL, NL-1100 DE AMSTERDAM, NETHERLANDS
[2] OSAKA CITY UNIV, SCH MED, DEPT PATHOL, OSAKA 545, JAPAN
[3] KYOTO UNIV, GRAD SCH MED, DEPT MED & CLIN SCI, KYOTO, JAPAN
关键词
natriuretic peptides; muscle; smooth; atherosclerosis;
D O I
10.1161/01.CIR.94.12.3103
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background C-type natriuretic peptide (CNP) belongs to the natriuretic peptide family and is considered to have regulatory effects on vascular tone and smooth muscle growth. Since these features play a role in atherogenesis, the presence of CNP at such sites was studied. Methods and Results Thirty-three coronary artery segments were harvested at autopsy: 10 normal, with diffuse intimal thickening, and 23 atherosclerotic lesions. Samples were snap-frozen and processed for immunohistochemical staining. For the identification of CNP, a mouse monoclonal antibody (KY-CNP-1) was used. 1A4, EBM-11 (CD68), and von Willebrand factor antibodies were used to stain smooth muscle cells, macrophages, and endothelial cells, respectively. CNP is present in several cell types. Normal arterial segments show CNP-positive endothelial cells. Hypercellular atherosclerotic lesions show distinct CNP positivity of smooth muscle cells and macrophages but a decrease in positivity of endothelial cells. Advanced atherosclerotic lesions contain CNP-positive macrophages, but the smooth muscle cells within the fibrous cap and the surface endothelial cells are almost all CNP-negative. Conclusions These observations suggest that CNP has functional significance in atherogenesis.
引用
收藏
页码:3103 / 3108
页数:6
相关论文
共 50 条
  • [1] Natriuretic peptide receptors in atherosclerotic lesions in human coronary arteries
    Naruko, T
    Ueda, M
    Haze, K
    vanderWal, AC
    vanderLoos, CM
    Becker, AE
    Suga, S
    Mukoyama, M
    Itoh, H
    CIRCULATION, 1996, 94 (08) : 4327 - 4327
  • [2] Vasodilatory action of a unique chimeric peptide to brain natriuretic peptide and C-type natriuretic peptide in human coronary microvessels
    Wei, CM
    Breu, M
    Gutterman, DD
    CIRCULATION, 1997, 96 (08) : 88 - 88
  • [3] C-type natriuretic peptide
    Barr, CS
    Rhodes, P
    Struthers, AD
    PEPTIDES, 1996, 17 (07) : 1243 - 1251
  • [4] HUMAN C-TYPE NATRIURETIC PEPTIDE - CHARACTERIZATION OF THE GENE AND PEPTIDE
    OGAWA, Y
    NAKAO, K
    NAKAGAWA, O
    KOMATSU, Y
    HOSODA, K
    SUGA, S
    ARAI, H
    NAGATA, K
    YOSHIDA, N
    IMURA, H
    HYPERTENSION, 1992, 19 (06) : 809 - 813
  • [5] C-type natriuretic peptide
    Ruskoaho, H.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2008, 102 : 10 - 10
  • [6] A novel designer natriuretic peptide integrating human C-type natriuretic peptide, atrial natriuretic peptide, and B-type natriuretic peptide
    Lee, Candace Y. W.
    Burnett, John C., Jr.
    FASEB JOURNAL, 2009, 23
  • [7] C-type natriuretic peptide in sepsis
    Mitaka, C
    Hirata, Y
    Sato, K
    Nagura, T
    Tsunoda, Y
    Amaha, K
    INTENSIVE CARE MEDICINE, 1997, 23 (03) : 354 - 355
  • [8] Mismeasure of C-type natriuretic peptide
    Nielsen, Soeren Junge
    Rehfeld, Jens F.
    Goetze, Jens Peter
    CLINICAL CHEMISTRY, 2008, 54 (01) : 225 - 227
  • [9] Urinary C-Type Natriuretic Peptide
    Zakeri, Rosita
    Sangaralingham, S. Jeson
    Sandberg, Sharon M.
    Heublein, Denise M.
    Scott, Christopher G.
    Burnett, John C., Jr.
    JACC-HEART FAILURE, 2013, 1 (02) : 170 - 177
  • [10] C-Type Natriuretic Peptide and Overgrowth
    Bocciardi, Renata
    Ravazzolo, Roberto
    ENDOCRINE INVOLVEMENT IN DEVELOPMENTAL SYNDROMES, 2009, 14 : 61 - 66